Chronic graft versus host disease

Chronic Graft-Versus-Host Disease (GVHD) is GVHD that developes later on after stem cell transplant, usually 100 days after and it is considered a long-term complication.

• It occurs when the donor's immune cells attack the recipient's body tissues, affecting organs like the skin, GI tract, lungs, liver, and eyes.

• Treatment includes immunosuppressive therapies and lifestyle modifications.

• By understanding the impact of chronic GVHD and engaging in proactive care, patients can better navigate this complex aspect of transplant recovery.

Why is it considered "Chronic"

• Timing: Chronic GVHD usually develops after the first 100 days post-transplant, but onset can vary.
• Duration: Unlike acute GVHD, which may resolve quickly with treatment, chronic GVHD often persists for months or years, and in some cases, becomes a lifelong condition.
• Symptoms: Chronic GVHD can resemble autoimmune diseases, with slow-developing symptoms and multi-organ involvement.
• Complexity: It often requires long-term immunosuppression, lifestyle adjustments, and coordinated care across specialties.